AstraZeneca (AZN) shares tumble amid intensifying concerns about a Chinese probe into the drugmaker. Josh Lipton and Julie Hyman examine the news driving the stock's moves.

To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

This post was written by Naomi Buchanan.